1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. IMMUNITYBIO INC
ImmunityBio Inc
XNAS: IBRX
8.45 -0.03 (-0.35%)
12.2M
XNAS Volume

XNAS 21 Sep, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert

ImmunityBio Inc - IBRX - stock price prediction, stock price target, analyst ratings from 4 analysts

ImmunityBio Inc has a share price target of US$ 13, revenue growth forecast of 99.2%, and profit growth estimate of -185.7% for FY26, based on top 4 analyst calls.